Implanon NXT - etonogestrel 68 mg, implant for subdermal use - Important Safety Information from MSD Ireland as approved by the HPRA

Notice type: 3rd Party Publications

Date: 20/01/2020

 

Problem Or Issue:

Important Safety Information from MSD Ireland - Update to the insertion and removal instructions to minimise the risks of neurovascular injury and implant migration of Implanon NXT– etonogestrel 68 mg, implant for subdermal use


Important Safety Information - Implanon NXT – etonogestrel 68 mg, implant for subdermal use

 



« Back